Drugs & Therapy Perspectives | 1995(05) articles
- Paclitaxel : a promising addition to the antineoplastic armamentarium
- Newer macrolides offer some advantages over erythromycin
- Anti-TNFα antibodies in RA : defining a major new direction for therapy?
- Addendum : New information on HRT
- Life-long drug therapy required for Wilson's disease
- Parkinsonism induced by drugs other than antipsychotics
- ABMT : keeping an eye on costs